Skip to main content
Skip to content
Case File
sd-10-EFTA01361373Dept. of JusticeOther

EFTA Document EFTA01361373

OCH-ZIFF Och-Ziff Professional Biographies CAPITAL MANAGEMENT GROUP ICS Investment Committee David Windreich is Head of U.S. and European Investing for Och-Ziff and is a member of OZM's Board of Directors and Partner Management Committee. Mr. Windreich is also an Executive Managing Director. Prior to joining Och-Ziff at its inception in 1994, Mr. Windreich was a Vice President in the Equity Derivatives Department of Goldman, Sachs & Co. He began his career at Goldman, Sachs & Co. in 1983

Date
Unknown
Source
Dept. of Justice
Reference
sd-10-EFTA01361373
Pages
1
Persons
0
Integrity
Loading PDF viewer...

Summary

OCH-ZIFF Och-Ziff Professional Biographies CAPITAL MANAGEMENT GROUP ICS Investment Committee David Windreich is Head of U.S. and European Investing for Och-Ziff and is a member of OZM's Board of Directors and Partner Management Committee. Mr. Windreich is also an Executive Managing Director. Prior to joining Och-Ziff at its inception in 1994, Mr. Windreich was a Vice President in the Equity Derivatives Department of Goldman, Sachs & Co. He began his career at Goldman, Sachs & Co. in 1983

Ask AI About This Document

0Share
PostReddit

Extracted Text (OCR)

EFTA Disclosure
Text extracted via OCR from the original document. May contain errors from the scanning process.
OCH-ZIFF Och-Ziff Professional Biographies CAPITAL MANAGEMENT GROUP ICS Investment Committee David Windreich is Head of U.S. and European Investing for Och-Ziff and is a member of OZM's Board of Directors and Partner Management Committee. Mr. Windreich is also an Executive Managing Director. Prior to joining Och-Ziff at its inception in 1994, Mr. Windreich was a Vice President in the Equity Derivatives Department of Goldman, Sachs & Co. He began his career at Goldman, Sachs & Co. in 1983 and became a Vice President in 1988. Mr. Windreich holds both a B.A. in Economics and an M.B.A. in Finance from the University of California, Los Angeles. He is a member of the Advisory Board of UCLA Anderson Fink Center for Finance and Investments and a Trustee of The Mount Sinai Medical Center. Harold Kelly is Head of Global Convertible and Derivative Arbitrage and Risk Management for Och-Ziff and is a member of Och-Ziff's Partner Management Committee. Mr. Kelly is also an Executive Managing Director. Prior to joining Och-Ziff in 1995, Mr. Kelly spent seven years trading various financial instruments and held positions at Cargill Financial Services Corporation, Eagle Capital Management, Merrill Lynch International, Ltd. and Buchanan Partners, Ltd. Mr. Kelly holds a B.B.A. in Finance and also holds an M.B.A. and a Ph.D. in Business Administration from the University of Georgia. Brett Klein is an Executive Managing Director and Head of U.S. Corporate Credit for Och-Ziff. Mr. Klein oversees performing and distressed credit investments in the U.S. with a focus on loans, bonds and credit derivatives. Prior to joining Och-Ziff in 2002, Mr. Klein was an Associate in the Investment Banking Division at Morgan Stanley. Mr. Klein holds a B.S. in Economics from the Wharton School of the University of Pennsylvania. Donald Young is a Managing Director and Senior Portfolio Manager, Institutional Credit Strategies for Och-Ziff. Prior to joining Och-Ziff in 2013, Mr. Young was a Senior Portfolio Manager at Octagon Credit Investors. Prior to that, he was a Senior Portfolio Manager at Primus Asset Management, Inc. Earlier, he was a Principal at Octagon Credit Investors as well as Senior Vice President at Bank of the West. Mr. Young holds a B.A. in Economics from Lafayette College and an M.B.A. in Finance from the University of Hawaii. Adeel Shafiqullah is a Managing Director and Senior Portfolio Manager, Institutional Credit Strategies — Europe for Och-Ziff. Prior to joining Och-Ziff in 2015, Mr. Shafiqullah was Head of European Leveraged Finance at Pinebridge Investments. Prior to that, he was an Investment Banking Analyst at Donaldson, Lufkin & Jenrette/Credit Suisse First Boston and Chanin Capital Partners. Mr. Shafiqullah holds a B.S. in Business Administration from the University of Southern California. Mathieu Clavel is a Managing Director and Head of European Corporate Credit for Och-Ziff. Prior to joining Och-Ziff in 2009, Mr. Clavel was a Senior Analyst at Silverpoint Capital. Before that, he worked as a Vice President at GSC Group and as an Analyst at Schroder Salomon Smith Barney. Mr. Clavel holds an M.S. in Accounting and Finance from the London School of Economics and Political Science. Tajinder Sidhu is a Managing Director and Head of European Private Investments for Och-Ziff. Prior to joining Och-Ziff in 2004, Mr. Sidhu was an Investment Banking Analyst at Merrill Lynch. Mr. Sidhu holds a B.S. in Mathematics from the University of Warwick Mathematics Institute. OCH-ZIFF CAPITAL MANAGEMENT GROUP CONFIDENTIAL - PURSUANT TO FED. R. GRIM. P. 6(e) CONFIDENTIAL DB-SDNY-0050533 SDNY_GM_00196717 42 EFTA01361373

Related Documents (6)

Dept. of JusticeNov 19, 2025

HOUSE OVERSIGHT 016696-Palm-Beach

November 12, 2025 release of Jeffrey Epstein documents by the House Committee on Oversight and Government Reform. Microsoft Excel Spreadsheets converted to PDF. Originals in NATIVES/001 folder

139p
Dept. of JusticeOtherUnknown

EFTA Document EFTA01378283

OCH-ZIFF Och-Ziff Professional Biographies CAPITAL MANAGEMENT GROUP ICS Investment Committee David Windreich is Head of U.S. and European Investing for Och-Ziff and is a member of OZM's Board of Directors and Partner Management Committee. Mr. Windreich is also an Executive Managing Director. Prior to joining Och-Ziff at its inception in 1994, Mr. Windreich was a Vice President in the Equity Derivatives Department of Goldman, Sachs & Co. He began his career at Goldman, Sachs & Co. in 1983

1p
Dept. of JusticeAug 22, 2017

17 August 1 through August 15 2016_Redacted.pdf

JAN 1 2 3 4 7a to 12p 0 4 0 7 1p to 5p 1 3 0 5 6p to 12a 2 0 1 10 1a to 6a 0 0 0 0 AVER 1 2 0 6 total  3 7 1 22 Year to date searches 5 7 12 9 4 8 32 6 26 8 3 2 10 39 7 18 7 8 0 8 33 763 8 18 5 3 2 7 28 9 4 4 0 0 2 8 10 0 0 0 0 0 0 11 12 3 1 0 4 16 12 13 16 23 20 17 3 2 0 7 10 12 39 49 Jan 14 15 16 17 11 20 4 1 19 15 3 0 3 7 0 0 0 0 0 4 8 11 2 1 33 42 7 5 Month Average 18 7 9 1 0 4 17 19 20 21 9 22 14 11 16 9 9 2 1 0 0 4 7 10 7 29 40 28 190.75 22 14 13 1 0 7 28 23 24 25 26 27 28 4 0

1793p
Dept. of JusticeMar 11, 2011

FBI USAMRID Investigation

011621Anthrax Page 1 of 1446 o I 2792\-WF-222936-'-USAMRIID - \\OC o I [he followijg investigation was conducted by Special Agent (SA)_ _of the federal Bureau of Investigation (FBI) on February 24, 2005: ? The United States Army Medical Research Institute of Infectious Diseases (USAMRIID) Keycard Access records from 1998 through 2002 were queried f r v' ? ? ? scientist nd visitin scient'st both ?rom the who have p eviously been identified as visiting USAMRIID circa May 1998. ;11 available

1446p
OtherUnknown

NAME SEARCHED: Mort, Inc

DOJ EFTA Data Set 10 document EFTA01295633

135p
Dept. of JusticeOtherUnknown

EFTA Document EFTA01470762

Deutsche Asset & Wealth Management Key Client Partners — U.S. Investment Themes and Solutions September 2014 For Internal Use Only Participant Dial-In: (877) 500-9123 International Dial In: (973) 796-5004 Conference ID: 9048-0259 Encore Dates: 9/10 — 9/30/2014 USA Free Call: (866) 247-4222 Conference ID: 9048-0259 U.S. Key Client Partner opportunities are available to Institutional Investors only. EFTA01470762 A global partner for our clients Deutsche Bank A leading global fin

47p

Forum Discussions

This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.

Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.